Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or C ...
A Phase 3 Randomized and Double-blind Controlled Trial Comparing the Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition to Rituximab in Adult Patients With Persistent or Chronic Immune Thrombocytopenia (ITP) A Phase 3 Randomized and Double-blind Controlled Trial Comparing the Efficacy and Safety of Subcutan ...